Good Doctor·Hot Infusion丨Made a stunning appearance at the 2024 CSCO Academic Annual Meeting
From September 26th to 28th, 2024, the 27th National Congress of Clinical Oncology and the 2024 CSCO Annual Meeting, themed "Patient-centric, Sharing the Future", was grandly held. Jointly organized by the Chinese Society of Clinical Oncology (CSCO) and the Beijing Hisk Clinical Oncology Research Foundation, this event served as a beacon, illuminating the path forward in the field of cancer treatment.
2024-09-26
From September 26th to 28th, 2024, the 27th National Congress of Clinical Oncology and the 2024 CSCO Annual Meeting, themed "Patient-centric, Sharing the Future," was grandly held. This event, jointly organized by the Chinese Society of Clinical Oncology (CSCO) and the Beijing Hisci Clinical Oncology Research Foundation, shone like a beacon, illuminating the path forward in the field of cancer treatment.

Good Doctor. Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Among the numerous exhibitors, Xi'an Good Doctor Medical Science and Technology Co., Ltd., a specialized medical technology company that is among the first domestically and internationally to adopt continuous circulation hyperthermic intraperitoneal chemotherapy (HIPEC) treatment technology and integrates R&D, registration, production, and sales, made a strong appearance at the conference with its excellent technological strength and innovative product concepts.

China Good Doctor, Friend of Humanity
"Extending Life, Enhancing Quality of Life." At the conference, the Good Doctor Medical booth was bustling with activity. Numerous domestic and foreign experts and industry professionals were attracted by the wide clinical application of Good Doctor HIPEC and the new treatment options it offers cancer patients, stopping to learn more. Experts engaged in in-depth discussions with company representatives, focusing on the hot topic of "Clinical Application of Intraperitoneal Hyperthermic Chemotherapy." Each person shared their rich experience and unique insights, sparking a continuous exchange of ideas and injecting continuous intellectual power into the development of the field of cancer treatment.
Academic Exchange
Good Doctor Medical has always considered providing more effective treatment options for cancer patients as its mission. Continuous circulation hyperthermic intraperitoneal chemotherapy (HIPEC) technology, like a shining pearl, has shown tremendous potential in clinical applications. This technology has not only brought new hope to patients but has also opened up new avenues in the field of cancer treatment. Through this conference, Good Doctor Medical not only showcased its strength to the world but also further strengthened its exchanges and cooperation with domestic and foreign counterparts. In this globalized era, win-win cooperation has become an unstoppable trend. Good Doctor Medical understands this well and actively works hand-in-hand with domestic and foreign counterparts to explore a new future for cancer treatment.


Innovation, Professionalism, Focus
Looking to the future, Xi'an Good Doctor Medical Science and Technology Co., Ltd. will continue to uphold the spirit of innovation, professionalism, and focus, constantly improving its technological level. Good Doctor understands that in the challenging field of cancer treatment, only continuous innovation can keep it at the forefront; only professionalism can win the trust of patients; and only by focusing on the cancer treatment cause can it bring more hope to patients. With the joint efforts of excellent companies such as Good Doctor Medical, the field of cancer treatment will surely usher in a brighter tomorrow. We have reason to believe that future cancer treatment will be more precise and effective, bringing the light of life to countless cancer patients, extending life, and enhancing the quality of life!
Key words:
Related News